James

Mannatech (NASDAQ:MTEX) announced that it has appointed James Clavijo as Chief Financial Officer, effective July 1. Clavijo has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron, Guided Therapeutics, Aeterna Zentaris, and Tri-source Pharma. MTEX +3.092% after hours to $7.0. Source: Press ReleaseContinue Reading